メチレン-C14-ダイオキシフェニル化合物:それらの相乗作用に関連した代謝
Science (New York, N.Y.)
|September 2, 1966
まとめ
マイクロソーマルヒドロキシル化により,メチレン-C(14) をフォームート-C(14) またはCO2に変換する. メチレンダイオキシフェニル化合物は,この酵素を阻害し,薬剤および殺虫剤の活性を拡張することができます.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- 毒理学 毒理学 毒理学
背景:
- 微小体酵素は,異種生物の代謝において重要な役割を果たします.
- メチレン基の水酸化は,重要な代謝経路である.
- これらの経路を理解することは,薬剤や農薬の開発に不可欠です.
研究 の 目的:
- メチレン-C(14) グループのインビトロおよびインビボの水酸化を調査する.
- この酵素系におけるメチレンダイオキシフェニル化合物の役割を決定する.
- 薬剤と殺虫剤の代謝への影響を調査する.
主な方法:
- ニコチナミド・アデニン・ディヌクレオチド・フォスファート系をマイクロソームに還元したインビトロ研究.
- 生きたマウスと家内ハエの体内研究.
- 代謝産物としてのフォーマット-C(14) と有効期限が切れたC(14) O(2) の分析.
主要な成果:
- メチレン-C(14) 群の水酸化により, in vitro でフォーマット-C(14) が得られました.
- 賞味期限が切れたC(14) O(2) は,in vivoで生成されました.
- メチレンダイオキシフェニル化合物は代替基板として作用し,水酸化率を低下させた.
結論:
- 微細化されたニコチナミド・アデニン・ディヌクレオチド・リン酸塩系はメチレン群を水酸化する.
- メチレンダイオキシフェニル化合物は,この水酸化を阻害し,ゼノバイオティクスの作用を延長する可能性があります.
- この発見は,薬剤の有効性と殺虫剤の持続性を最適化するための意味を持つ.
関連する概念動画
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...